Showing posts with label Diabetic Nephropathy. Show all posts

9/09/2026

Advances in Diabetes Care: Upgrading Insulin Pump Technology and Exploring New Therapies for Kidney Protection

Journal of Diabetes Investigation: Vol. 17, Issue 4 Summary

This issue highlights key advancements spanning both advanced diabetes technology and foundational pharmacology. Together, these studies emphasize the rapid evolution of modern diabetes management, showing how patient care is being optimized in real-world clinical practice and pointing toward future organ-protective strategies.

Advanced Diabetes Technology: Real-world evidence demonstrates that upgrading from the MiniMed™ 770G to the 780G hybrid closed-loop system significantly improves blood sugar stability, reduces night-time hypoglycemia, and eases diabetes-related anxiety in adults with Type 1 Diabetes.
Preventing Complications: Preclinical research shows that Calebin A, a natural compound, targets inflammation and cell damage pathways to protect kidneys from diabetic nephropathy.
Relevance to Care: These findings highlight the physical and psychological benefits of upgrading medical devices, while offering hope for novel, protective therapies that could shield patients from long-term diabetic complications.

Disclaimer The information presented in this article is provided for informational purposes only. The blog and its author assume no responsibility for the accuracy, safety, completeness, or reliability of the information. Any actions or decisions based on the information in this article are the sole responsibility of the reader.

This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.

Clinical Research & Technology

Effects of switching from MiniMed™ 770G to 780G on continuous glucose monitoring metrics and DTR-QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

Authors: Eri Takagi, Junko Sato, Tatsuhiro Ayame, Shohei Fujikawa, Ryoki Mori, Haruna Yasuda, Azusa Ozaki, Haruki Nagashima, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada

Research Objective:

To evaluate how switching from the MiniMed™ 770G insulin pump to the newer MiniMed™ 780G system affects blood sugar levels and quality of life (QOL) in Japanese adults with Type 1 Diabetes (T1D) over a one-year period.

Methods:

The researchers retrospectively analyzed continuous glucose monitoring (CGM) data from 36 adult patients over 48 weeks. They evaluated the time spent in the ideal blood sugar range (70–180 mg/dL), as well as high and low blood sugar levels. Additionally, they prospectively measured treatment-related quality of life (DTR-QOL) in 39 patients using standard questionnaires.

Main Findings:

Time in Range (70-180 mg/dL): Significantly increased from 71.6% to 76.1%.
High Blood Sugar: Time spent above 180 mg/dL decreased from 25.2% to 21.0%.
Hypoglycemia: While overall low blood sugar rates remained stable, nighttime low blood sugars (nocturnal hypoglycemia) dropped significantly from 4.9% to 2.7%.
A1C Levels: Average HbA1c improved from 7.2% to 7.0%.
Quality of Life: Patients reported significantly lower levels of diabetes-related anxiety and higher overall satisfaction with their treatment.

Clinical Significance:

This study provides the first one-year, real-world evidence of MiniMed™ 780G use in Japan. It demonstrates that the newer system's automated features translate directly to more stable blood sugars and happier, less anxious lives for patients.

Key Points for Patients & Families Upgrading from the MiniMed™ 770G to the 780G system can help keep your blood sugar in the healthy range longer and lower your HbA1c. Most notably, the 780G reduces the risk of dangerous blood sugar drops overnight and significantly eases daily diabetes stress and anxiety.

DOI: https://doi.org/10.1111/jdi.70257 (Read the original article)

Basic & Animal Research

Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/HO‐1 and NF‐κB signaling pathways

Authors: Reyhane Ghayour Vatanparast, Mahdieh Aliyari, Mahla Palizkaran Yazdi, Soodeh Alidadi, Mohammad Reza Sokhanvar, Sercan Karav, Prashant Kesharwani, Hossein Hosseini, Amirhossein Sahebkar

Research Objective:

To study the potential kidney-protecting (nephroprotective) properties and the underlying biological mechanisms of Calebin A, a natural compound related to turmeric, in treating diabetic nephropathy (kidney disease).

Methods:

Diabetic nephropathy was induced in mice. The mice were then treated with Calebin A, curcumin, or metformin for six weeks. Researchers examined their blood sugar, kidney function, signs of cell stress, inflammation, and physical scarring (fibrosis) in the kidney tissues.

Main Findings:

Kidney Protection: Calebin A treatment significantly improved blood sugar control and overall kidney performance.
Pathology Improvement: Tissue samples showed less physical damage and scarring in the kidneys of treated mice.
Cellular Mechanism: It successfully reduced harmful cell stress by boosting the body's natural antioxidant defense (Nrf2 pathway) and reduced swelling by blocking the inflammatory pathway (NF-κB pathway).

Clinical Significance:

These findings show that Calebin A holds strong potential as a multi-target natural therapy to protect kidneys from high blood sugar damage. However, because this was an animal study, further clinical trials are necessary to confirm if these protective effects work similarly in humans.

Key Points for Patients & Families Diabetic kidney disease is a serious complication caused by long-term high blood sugar. This promising laboratory study reveals that Calebin A (a natural compound) could serve as a future therapeutic option to help protect kidneys from swelling, scarring, and permanent damage.

DOI: https://doi.org/10.1111/jdi.70267 (Read the original article)

9/08/2026

New Insights in Diabetes Care: From Molecular Protectors of Vision to the Balance-Boosting Power of Tai Chi

Journal of Diabetes Investigation: Vol. 16, Issue 11 Review

The November 2025 issue of the Journal of Diabetes Investigation highlights key clinical themes focused on multi-organ diabetic complications, innovative molecular markers, and effective therapeutic exercises. Key research areas explore molecular pathways in diabetic retinopathy and gestational diabetes, simple blood-based predictive biomarkers for neuropathy mortality, and the complex links between fatty liver disease and bone health. Additionally, a notable clinical trial highlights the practical role of supervised Tai Chi Chuan in significantly improving balance and reducing fall risks for older adults dealing with both type 2 diabetes and mild cognitive impairment.

Key Takeaways for Patients and Families:

Accessible Exercise: Tai Chi is highly effective—even more than standard walking—at protecting older adults with diabetes from dangerous falls and building daily movement confidence.
Targeted Future Treatments: Discoveries in microscopic genetic markers (like miR-21-5p, CFL2, and OIP5-AS1) are paving the way for targeted treatments that aim to arrest kidney and eye damage before they progress.
Comprehensive Screening: Managing fatty liver and monitoring blood triglyceride levels are vital step-stones to ensuring bone health and avoiding osteoporosis in diabetic patients.

Diabetic Retinopathy

SP1-activated CFL2 Promotes High Glucose-Induced Retinal Pigment Epithelial Cell Injury

Authors: Jinan Xiao, Jingni Yu, Mei Ren

Research Objective: To investigate the role and molecular mechanism of Cofilin-2 (CFL2) in the progression of diabetic retinopathy (DR), specifically focused on how it impacts retinal pigment epithelial (RPE) cells under high-sugar conditions.

Methods: Researchers used a cell model where human retinal pigment epithelial cells (ARPE-19) were cultured in high-glucose (HG) environments to mimic diabetic retinopathy. Cell growth, cell death (apoptosis), cellular stress (oxidative stress and ferroptosis), and inflammation were evaluated under different genetic conditions, including the silencing of CFL2 and knockdown of the transcription factor SP1.

Main Findings: High glucose severely damaged the retinal cells, stopping growth while inducing cell death, oxidative stress, and inflammation. Silencing CFL2 successfully rescued the cells from this glucose-induced damage. The study also revealed that a protein called SP1 binds to CFL2 to increase its expression, and knocking down SP1 protected the cells. Additionally, SP1 knockdown worked by turning down the activity of the AMPK/mTOR pathway, a key cellular signaling system.

Clinical Significance: By identifying the SP1/CFL2 pathway as a driver of high-glucose-induced eye damage, this study highlights a potential new therapeutic target to protect the vision of individuals with diabetic retinopathy.

Key Points for Patients: When blood sugar is high, specific proteins in the eye trigger inflammation and cell damage. Understanding these tiny molecular switches helps scientists develop new, targeted eye drops or therapies to prevent vision loss in the future.

Read the original article: https://doi.org/10.1111/jdi.70144

Fatty Liver & Bone Health

Relationship Between Liver Fibrosis and Femoral Neck Bone Mineral Density in Patients with T2DM and Fatty Liver

Authors: Jie Tao, Lin Wang, Honggang Wang, Juan Tan

Research Objective: To analyze how liver scarring (fibrosis) affects hip bone density (femoral neck BMD) in patients who have both type 2 diabetes and metabolic dysfunction-associated fatty liver disease (MAFLD).

Methods: A retrospective study was conducted on 569 hospitalized patients with both type 2 diabetes and MAFLD. Liver fibrosis was estimated using the Fibrosis-4 (FIB-4) score, and bone density was measured via standard dual-energy X-ray absorptiometry (DXA) scans.

Main Findings: In postmenopausal women and men aged 50 and older, there was a non-linear, "inverted U-shaped" link between liver fibrosis and bone density, with a threshold value of FIB-4 = 2.091. Below this value, mild fibrosis was associated with higher bone density. However, in patients with high triglycerides (1.7 mmol/L or more), liver fibrosis was significantly associated with decreased bone density.

Clinical Significance: High triglycerides represent a major risk factor for osteoporosis in diabetes patients with fatty liver disease. These findings suggest that patients with high triglycerides and fatty liver should be actively screened for bone loss.

Key Points for Patients: Having type 2 diabetes along with fatty liver disease can impact your bone strength, especially if your triglycerides are high. Keeping your blood lipids in a healthy range is important not just for your heart and liver, but also to protect you from bone fractures.

Read the original article: https://doi.org/10.1111/jdi.70129

Gestational Diabetes

NSUN2-Mediated m5C Methylation Modifies Placental Trophoblast Cells in Gestational Diabetes

Authors: Jiujiu Liu, Yingjun Chen, Dapeng Wang, Zhaozhao Li

Research Objective: To investigate how the RNA-modifying enzyme NSUN2 and its chemical modification (m5C methylation) regulate key placental cells (trophoblasts) in gestational diabetes mellitus (GDM).

Methods: The research team examined the expression levels of the NSUN2 gene and evaluated its effects on cell growth, programmed cell death (apoptosis), and cell cleanup processes (autophagy) in a trophoblast cell line (HTR-8/SVneo).

Main Findings: Trophoblast cells exhibited high expression of the NSUN2 gene. The study demonstrated that NSUN2-mediated m5C methylation directly regulates trophoblast cell proliferation, survival, and cellular waste management (autophagy).

Clinical Significance: These molecular insights reveal how high blood sugar during pregnancy alters placental function at an epigenetic level, offering a potential focus for preventing complications related to gestational diabetes.

Key Points for Patients: Gestational diabetes doesn't just affect blood sugar; it changes how cells in the placenta function and grow. Scientists are mapping these changes to find better ways to keep both mom and baby healthy during pregnancy.

Read the original article: https://doi.org/10.1111/jdi.70140

Diabetic Neuropathy

Red Cell Distribution Width and RDW-to-Albumin Ratio as Long-Term Mortality Predictors in Diabetic Neuropathy

Authors: Jui‐Chu Huang, Pey‐Jium Chang, Yi‐Lun Chiang

Research Objective: To evaluate if two simple blood markers—Red Cell Distribution Width (RDW) and the RDW-to-Albumin Ratio (RAR)—can predict long-term all-cause and cardiovascular disease (CVD) death in patients with diabetic neuropathy.

Methods: This long-term study tracked 624 adults aged 40 and older with diabetic neuropathy from the National Health and Nutrition Examination Survey (NHANES, 1999–2019). The predictive accuracy of RDW and RAR was statistically modeled.

Main Findings: Over the follow-up period, each unit increase in RDW raised all-cause mortality by 12% and CVD mortality by 15%. Even more significantly, each unit increase in RAR increased all-cause mortality by 73% and CVD mortality by 93%. Patients in the highest tier of RAR faced nearly 5 times the risk of cardiovascular death compared to those in the lowest tier. RAR proved to be highly accurate in predicting five-year survival rates.

Clinical Significance: RAR is a highly powerful and easily accessible clinical marker that can identify high-risk diabetic neuropathy patients who require intensive cardiovascular protection.

Key Points for Patients: Neuropathy (nerve damage) is a common complication of diabetes. Simple markers in routine blood tests, like the ratio of red blood cell size variation to protein levels, can help your doctor keep a closer eye on your heart health.

Read the original article: https://doi.org/10.1111/jdi.70147

Diabetic Nephropathy

Dysregulation of miR-21-5p in Diabetic Nephropathy and Its Role in Inflammatory Response

Authors: Yujiang Zhang, Qin Deng, Jianping Yi

Research Objective: To investigate the diagnostic potential and biological role of a tiny molecule in the blood, miR-21-5p, in diabetic kidney disease (diabetic nephropathy).

Methods: Blood samples were compared among three groups: 106 patients with type 2 diabetes, 106 with diabetic nephropathy, and 70 healthy controls. Researchers correlated miR-21-5p levels with standard kidney function measurements (eGFR and protein in urine) and studied the molecule in cultured human kidney cells (mesangial cells).

Main Findings: Serum miR-21-5p levels were significantly elevated in patients with diabetic nephropathy and successfully distinguished them from patients with standard diabetes. Higher levels of miR-21-5p correlated with lower kidney function (eGFR) and higher protein loss in urine (UAER). In laboratory experiments, turning off (knocking down) this molecule reduced inflammatory responses and cell overgrowth caused by high glucose.

Clinical Significance: Serum miR-21-5p functions as both a promising diagnostic marker and a potential therapeutic target that, when blocked, might slow down kidney inflammation and damage.

Key Points for Patients: Over time, high blood sugar can damage the kidneys. This study found a specific biomarker in the blood that rises as kidney function declines. Detecting this marker early could help doctors step in before serious kidney damage occurs.

Read the original article: https://doi.org/10.1111/jdi.70098

Diabetic Retinopathy

Dysregulation of lncRNA OIP5-AS1 Affects Vascular Growth in Diabetic Retinopathy

Authors: Ziwen Yin, Jingyun Dong, Yachao Meng, Zhiqiang Yang, Chunhong Zhao, Qiuyun Wu

Research Objective: To evaluate the clinical significance and cellular function of the long non-coding RNA OIP5-AS1 in patients with diabetic retinopathy.

Methods: The study compared OIP5-AS1 levels in 85 healthy controls, 79 patients with type 2 diabetes, and 114 patients with diabetic retinopathy. Its effects on human retinal vascular endothelial cells (HRVECs) under high glucose conditions were examined.

Main Findings: OIP5-AS1 levels were significantly lower in patients with diabetic retinopathy, and its depletion was linked with severe, proliferative eye damage. Under high glucose, retinal vessel cells lost this protective molecule. Restoring OIP5-AS1 levels stopped the abnormal cell growth by interacting with another molecule, miR-181a-5p, which is associated with aging and cell stress pathways.

Clinical Significance: OIP5-AS1 acts as a protective shield against abnormal retinal blood vessel growth in diabetes. Restoring its levels represents a promising strategy to prevent vision loss in diabetic patients.

Key Points for Patients: Diabetic retinopathy causes abnormal blood vessels to grow in the back of the eye. Scientists have identified a protective molecule that drops in patients with this condition. Finding ways to boost this natural protector could help keep eye vessels healthy.

Read the original article: https://doi.org/10.1111/jdi.70091

Clinical Trial / Lifestyle

Effects of Tai Chi Chuan on Balance Function in Older Adults with Type 2 Diabetes and Mild Cognitive Impairment

Authors: Jiawei Qin, Jia Huang, Jue Liu, Yannan Chen, Jia Luo, Liyuan Tao, et al.

Research Objective: To compare the effectiveness of Tai Chi Chuan against fitness walking and educational controls on balance, physical strength, and fall prevention in older adults (60+) with type 2 diabetes and mild cognitive impairment (MCI).

Methods: A rigorous randomized clinical trial assigned 328 older adults in China to three groups: Tai Chi Chuan (60 mins, 3x/week for 24 weeks), fitness walking (same frequency), or educational control. All participants were followed up to 36 weeks. Assessments measured balance, walking while thinking (dual-task tests), standing stability, leg strength, and the actual number of falls.

Main Findings: By week 36, the Tai Chi group showed significantly greater improvements in complex walking balance, single-leg standing time, reach distance, sit-to-stand speed, and overall balance confidence compared to the walking group. Most importantly, the Tai Chi group had significantly fewer total falls over the 36-week trial period.

Clinical Significance: Tai Chi Chuan is superior to simple walking as an exercise intervention to improve coordination and prevent dangerous falls in diabetic seniors dealing with memory or cognitive challenges.

Key Points for Patients: If you or an older loved one is managing both diabetes and mild memory slips, Tai Chi is a highly effective, safe exercise. It outshines standard walking by building double the confidence, strengthening legs, and significantly lowering the risk of accidental falls.

Read the original article: https://doi.org/10.1111/jdi.70138

Latest Insights in Diabetes Care: From Glycemic Fluctuations and Genetic Markers to Neuropathy and Longevity

Journal of Diabetes Investigation: Vol. 16, Issue 8 Summary

This issue brings together a diverse array of clinical and laboratory research focused on improving our understanding of diabetes complications, diagnosis, and long-term health outcomes. Key themes in this month's issue include:

Complications & Neuropathy: Exploring how fluctuations in blood sugar damage nerves, and how nerve damage in turn impacts stomach function.
Genetic Insights: Uncovering specific gene mutations linked to rare insulin-resistant syndromes and common diabetic kidney complications.
Obesity & Insulin Resistance: Examining how fat cells communicate with muscle tissue via microscopic particles to block glucose uptake.
Mortality and Longevity: Evaluating the leading causes of death in people with diabetes in Japan and analyzing how definitions of diabetes affect clinical research outcomes.

Key Takeaway for Patients: Managing diabetes effectively involves looking beyond standard average blood sugar levels (HbA1c) to focus on avoiding sudden blood sugar spikes and drops, monitoring for subtle symptoms of nerve damage, and maintaining overall metabolic health.

Longevity & Mortality Trends

Differences in Cause of Death and Age at Death in People with Diabetes in Japan

Research Objective: To compare the causes of death and the average age at death between individuals with and without diabetes under identical clinical conditions, and to evaluate how different ways of defining "diabetes" in medical records change these outcomes.

Methods: Researchers analyzed the records of inpatients who passed away at the National Center for Global Health and Medicine in Japan between September 2010 and December 2020. Patients with and without diabetes were classified using medication prescriptions and lab results. The primary cause of death was determined by the clinical records provided by attending physicians.

Main Findings: In both groups, malignant neoplasia (cancer) was the leading cause of death, but it was more common in individuals with diabetes (36.9%) compared to those without (31.0%). Interestingly, in this study population, the average age at death was slightly higher for individuals with diabetes (75.0 years) than those without (73.8 years). Crucially, the researchers noted that depending on the exact medical definition used to identify "diabetes" in the records, the calculated average age at death varied by up to 1.5 years.

Clinical Significance: This study suggests that modern diabetes management in Japan may support survival to older ages, with cancer remaining the primary threat. It also highlights a major scientific warning: researchers must be highly consistent and careful with how they define diabetes in databases, as small definition changes can alter mortality statistics.

Key Points for Patients: With high-quality modern care, people with diabetes in Japan are living long lives. Because cancer is the leading cause of death, staying up-to-date with routine cancer screenings is incredibly important for long-term health.

DOI: https://doi.org/10.1111/jdi.70067

Nerve Health & Glycemic Spikes

Impact of Blood Sugar Fluctuations on Nerve Damage in Well-Controlled Type 2 Diabetes

Research Objective: To investigate if rapid fluctuations in blood sugar (glycemic variability), both over the short-term (day-to-day) and long-term (month-to-month), contribute to diabetic nerve damage (neuropathy) even in patients whose overall blood sugar levels are considered well-controlled.

Methods: This prospective study in Taiwan followed 82 participants with well-controlled Type 2 Diabetes. Long-term fluctuations were tracked using visit-to-visit HbA1c measurements over a year. Short-term fluctuations were tracked using quarterly 7-day fingerstick records (evaluating fluctuations in "Time-in-Range"). Nerve function was thoroughly assessed using clinical scoring systems, nerve conduction tests, and skin sensation tests at the beginning of the study and at a one-year follow-up.

Main Findings: Patients with highly fluctuating blood sugar levels—regardless of whether those fluctuations were short-term or long-term—showed significantly higher scores for nerve dysfunction and lower thresholds for detecting temperature changes at the start. After one year, clinical nerve damage scores increased significantly in both high-fluctuation groups compared to patients with stable blood sugar, even though their average glucose numbers were similar.

Clinical Significance: Having a stable average blood sugar is not always enough to protect nerves. Both short-term and long-term blood sugar "rollercoasters" actively damage both large and small nerve fibers over time.

Key Points for Patients: To protect your feet and hands from numbness or pain (neuropathy), talk to your doctor about strategies to minimize sharp spikes and drops in your blood sugar. Keeping your blood sugar steady is just as vital as keeping your overall HbA1c low.

DOI: https://doi.org/10.1111/jdi.70079

Genetic Syndromes

How PIK3R1 Gene Mutations Disrupt Insulin Signaling in SHORT Syndrome

Research Objective: To describe the clinical characteristics of Japanese patients with SHORT syndrome—a rare genetic condition associated with growth issues and severe insulin resistance—and use advanced computer modeling to study how their specific genetic mutations damage insulin pathways.

Methods: Researchers performed genetic sequencing on four individuals from three Japanese families with SHORT syndrome. They then built 3D computer models of the altered protein (p85α) to simulate exactly how the genetic mutations prevent it from binding with other molecules required for normal insulin signaling.

Main Findings: The study identified two families with a known mutation and one family with a brand-new mutation. The 3D modeling showed that both mutations severely damaged the protein's shape, preventing it from binding to key signaling peptides and effectively blocking the pathway insulin uses to tell cells to absorb sugar. Interestingly, one patient developed diabetes without showing typical signs of severe insulin resistance, pointing to unexpected clinical diversity.

Clinical Significance: By mapping these mutations at a molecular level, this study confirms exactly why these genetic variations lead to early-onset diabetes, while highlighting that patients with the same genetic syndrome can still present with vastly different clinical symptoms.

Key Points for Patients: This basic science research helps doctors understand the precise root causes of rare, genetically-driven forms of diabetes, paving the way for more targeted, personalized therapies in the future.

DOI: https://doi.org/10.1111/jdi.70062

Diabetic Kidney Disease Genetics

Inflammatory Gene Variant Linked to Kidney Disease in Type 1 Diabetes

Research Objective: To investigate if genetic variations in Interleukin-6 (IL-6)—a key inflammatory signal—and its receptor (IL-6R) are associated with the risk of developing diabetes or its long-term complications, such as kidney damage, in a Czech population.

Methods: A clinical study was conducted with 669 participants, including healthy individuals, patients with Type 1 Diabetes, and patients with Type 2 Diabetes. The researchers looked at specific genetic variations (polymorphisms) and compared them with clinical markers like kidney filtration rate (GFR) and kidney complications (nephropathy).

Main Findings: While the genetic variants did not make people more likely to develop diabetes itself, a specific variation in the IL-6 receptor gene (called IL-6R Asp358Ala) was strongly linked to diabetic nephropathy (kidney disease). When looking closely at the groups, this genetic link to kidney complications was highly significant in patients with Type 1 Diabetes, showing an almost threefold increase in risk.

Clinical Significance: Chronic inflammation is known to play a role in diabetes complications. This study highlights a specific genetic pathway in inflammation that puts Type 1 Diabetes patients at a much higher risk for kidney damage, suggesting that anti-inflammatory targets might protect the kidneys.

Key Points for Patients: Our genes can make some of us more prone to complications like kidney disease. Identifying these markers early can help doctors provide closer monitoring and more aggressive kidney-protective care for those who need it most.

DOI: https://doi.org/10.1111/jdi.70073

Obesity & Insulin Action

How Obesity Causes Muscles to Resist Insulin: The Role of Fat Cell Exosomes

Research Objective: To determine how a microscopic regulatory molecule (miR-4472), which is elevated in obesity, travels from fat tissue to skeletal muscles to impair their ability to absorb sugar and cause insulin resistance.

Methods: This study used human blood samples, laboratory cell models, and obese mouse models. Researchers analyzed "exosomes"—tiny packages released by fat cells that travel through the blood—to see how they deliver miR-4472 to muscle cells, and tested whether blocking this pathway could restore insulin sensitivity.

Main Findings: The level of miR-4472 in the blood strongly correlates with body measurements like BMI and waist size. In obesity, fat cells release exosomes filled with miR-4472 into the bloodstream. When these packages reach muscle cells, they shut down key proteins (MEF2D and GLUT4) that muscles use to pull glucose out of the blood. Excitingly, blocking these microscopic packages or the molecule itself completely reversed insulin resistance in obese mice.

Clinical Significance: This study maps out a previously unknown communication pathway between fat and muscle. It identifies miR-4472 as a major culprit in obesity-induced Type 2 Diabetes and highlights a potential new biological target for treating insulin resistance.

Key Points for Patients: Obesity doesn't just store extra energy; it actively changes how different tissues in the body talk to each other. Understanding these "hidden messages" helps scientists develop future drugs that could block insulin resistance at its source.

DOI: https://doi.org/10.1111/jdi.70054

Gastrointestinal Complications

Using Ultrasound to Detect Stomach and Intestines Slowdown in Diabetic Neuropathy

Research Objective: To evaluate how nerve damage in Type 2 Diabetes affects the movement of the stomach and intestines (motility) using a non-invasive tool: gastric filling ultrasound.

Methods: The study compared 210 individuals divided into three groups: healthy controls, diabetic patients without neuropathy, and diabetic patients with neuropathy. Researchers used ultrasound to look at how quickly the stomach emptied after a meal, stomach wall thickness, and total stomach capacity. They also measured gut-related hormones (motilin and glucagon) in the blood.

Main Findings: Patients with diabetic neuropathy had significantly slower stomach emptying, felt much more full after meals, and had slower small intestinal transit times. Ultrasound revealed they had physically reduced stomach capacity and thicker stomach walls. These physical changes were accompanied by lower levels of motilin (a hormone that triggers stomach movement) and higher levels of glucagon (which slows digestion).

Clinical Significance: Nerve damage from diabetes directly impairs the digestive tract, resulting in a condition called gastroparesis. This study proves that gastric filling ultrasound is a highly effective, non-invasive, and objective tool to measure these digestive delays in a clinical setting.

Key Points for Patients: If you have diabetes and experience frequent bloating, feeling excessively full after small meals, or nausea, it could be a sign that your nerves are affecting your digestion. Non-invasive ultrasound tests can help your doctor easily check how well your stomach is working.

DOI: https://doi.org/10.1111/jdi.70059

9/06/2026

Understanding Glycemic Variability, Autoimmune Diabetes Genetics, and Diabetic Kidney Disease Pathways

Journal of Diabetes Investigation: Vol. 15, Issue 1 Summary

This issue of the Journal of Diabetes Investigation brings together vital research focusing on the genetics, complications, and management tools of diabetes. The primary themes highlight how cutting-edge tools and genetic research can help personalize medicine and protect patients from long-term complications.

Key highlights include an exploration of the biological pathways behind diabetic kidney disease (nephropathy) and the identification of a genetic marker (the RPS26 gene) that could distinguish autoimmune types of diabetes (such as Type 1 and LADA) from Type 2 diabetes. Additionally, a comprehensive review of glycemic variability emphasizes the clinical value of Continuous Glucose Monitors (CGMs) in tracking blood sugar fluctuations to potentially prevent tissue damage.

For patients, families, and healthcare providers, these studies underscore a shift toward precision care—using advanced monitoring technology and genetic profiling to tailor treatments and mitigate complications before they progress.

Diabetic Nephropathy & Genetics

Identification and validation of voltage‐dependent anion channel 1‐related genes and immune cell infiltration in diabetic nephropathy

Authors: Jiaqun Lin, Mengjie Weng, Jing Zheng, Kun Nie, Siyi Rao, Yongjie Zhuo, Jianxin Wan

Research Objective:
To investigate the specific genes related to "voltage-dependent anion channel 1" (VDAC1) and analyze their connection with immune system activity (immune cell infiltration) in diabetic kidney disease (diabetic nephropathy).

Methods:
The researchers analyzed data from public gene expression databases of patients with diabetic nephropathy. They pinpointed key genes (hub genes) and analyzed their pathways. They then checked how these genes correlate with immune cells and validated their protein levels in laboratory models of diabetic mice (db/db mice). Finally, they searched for potential drugs that might target these genes to help slow down kidney damage.

Main Findings:
They discovered 57 VDAC1-related genes involved in major inflammatory and metabolic pathways (like PI3K, Notch, and TGF-β) in diabetic nephropathy. Specifically, five "hub" genes (ITGAM, B2M, LYZ, C3, and CASP1) were found to be highly active in the kidneys of diabetic mice and were strongly linked to the presence of immune cells.

Clinical Significance:
These findings show that immune system activation and specific cellular channels are deeply involved in diabetic kidney damage. Identifying these five hub genes provides prospective diagnostic markers and targets for developing new medications designed to protect the kidneys of patients with diabetes.

Key Points for Patients:
Researchers are mapping out the precise genetic and immune system changes that cause kidney damage in diabetes. Understanding these specific gene pathways is a major step toward creating target-specific drugs to prevent or treat diabetic kidney disease in the future.

DOI: https://doi.org/10.1111/jdi.14087
Read the original article →

Blood Sugar Dynamics & Technology

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?

Authors: Yifei Mo, Jingyi Lu, Jian Zhou

Research Objective:
To review how "glycemic variability" (blood sugar swings between extreme highs and lows) is measured, its targets, how it damages tissue, and its relationship with long-term diabetes complications.

Methods:
The authors summarized scientific literature from the past two decades, with a focus on Continuous Glucose Monitoring (CGM) devices, which track real-time sugar fluctuations. They evaluated clinical studies, biological tissue mechanisms, and population data.

Main Findings:
Continuous glucose monitoring provides a complete picture of sugar fluctuations that traditional HbA1c tests can miss. While many clinical studies link high glycemic variability to diabetes complications, especially in Type 2 diabetes, long-term clinical trials are still needed to clarify exactly how much blood sugar swings alone directly cause tissue damage.

Clinical Significance:
This review highlights glycemic variability as an important clinical metric alongside standard average blood sugar (HbA1c). It helps establish standards for how doctors assess blood sugar stability.

Key Points for Patients:
Keeping blood sugar steady is just as important as keeping your average numbers down. Rapid spikes and drops can stress your blood vessels. Using a Continuous Glucose Monitor (CGM) can help you see and manage these daily fluctuations.

DOI: https://doi.org/10.1111/jdi.14112
Read the original article →

Genetic Biomarkers & Diabetes Classification

Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals

Authors: Rong Song, Lingxiang Xie, Jin Ding, Yan Chen, Hailan Zou, Haipeng Pang, Yiman Peng, Ying Xia, Zhiguo Xie, Xia Li, Yang Xiao, Zhiguang Zhou, Jingyi Hu

Research Objective:
To determine if a specific genetic variation in the RPS26 gene (rs1131017) is linked to a higher risk of developing different types of diabetes (Type 1, LADA, or Type 2) in the Chinese Han population.

Methods:
The researchers examined the genetic information of 1,006 patients with Type 1 diabetes, 210 patients with LADA (Latent Autoimmune Diabetes in Adults), 642 patients with Type 2 diabetes, and 2,099 healthy control subjects. They also studied how this gene variation related to the patients' clinical features, like C-peptide levels (which show how much insulin the body produces).

Main Findings:
They found that a specific variation (carrying the "C allele") of the RPS26 gene significantly increases the risk of both Type 1 diabetes and LADA. Interestingly, this risk was not associated with Type 2 diabetes. Furthermore, patients with this gene variant produced less insulin (measured via lower postprandial or fasting C-peptide levels).

Clinical Significance:
The RPS26 gene variation serves as a clear genetic marker that distinguishes autoimmune types of diabetes (Type 1 and LADA) from non-autoimmune Type 2 diabetes. This genetic marker is directly linked to the body's impaired capacity to produce insulin.

Key Points for Patients:
Because different types of diabetes require different management strategies, getting an accurate diagnosis is critical. Discovering genetic markers like the RPS26 variant helps doctors identify and classify autoimmune forms of diabetes early, leading to more tailored and effective treatment plans.

DOI: https://doi.org/10.1111/jdi.14117
Read the original article →

9/05/2026

Advances in Diabetes Care: From Weight-Loss-Driven Inflammation Relief to Kidney Protection Mechanisms

Journal of Diabetes Investigation: Vol. 14, Issue 9 Summary

This issue of the Journal of Diabetes Investigation brings to light critical connections between metabolism, immune response, and organ damage. The featured studies span from practical clinical observations to foundational scientific reviews and advanced molecular research, emphasizing three core themes:

Metabolic & Inflammatory Intersections: How obesity and type 2 diabetes fuel chronic inflammation, affecting organs beyond the pancreas, such as the skin (psoriasis) and blood vessels.
The Foundation of Medical Discovery: The historical and ongoing importance of animal models in translating laboratory findings into real-world human diabetes therapies.
Targeted Organ Protection: Pinpointing the exact genetic and cellular mechanisms responsible for diabetic kidney disease (nephropathy) to design highly specific future treatments.

Key Takeaway for Patients: Daily lifestyle management remains extremely powerful for reducing full-body inflammation, while laboratory breakthroughs continue to pave the way for next-generation, targeted medications.

Clinical Case Study & Inflammation

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events

Authors: Yoshiro Maezawa, Yusuke Endo, Satomi Kono, Tomohiro Ohno, Yuumi Nakamura, et al.

Research Objective

To determine whether treating obesity through lifestyle changes can reduce a specific type of inflammatory immune cell (T helper 17, or Th17 cells) and subsequently improve associated chronic inflammatory diseases like psoriasis.

Methods

The researchers studied an individual with obesity, type 2 diabetes, and psoriasis. The patient underwent a structured weight-loss program consisting of diet and exercise. Researchers monitored changes in body weight, psoriasis severity, and the levels of inflammatory Th17 cells in the body.

Main Findings

Prior to the intervention, the patient had elevated levels of Th17 immune cells. Following successful weight loss via diet and exercise, there was a measurable decrease in Th17 cells alongside a noticeable improvement in their psoriasis skin symptoms.

Clinical Significance

This clinical case supports the medical theory that obesity alters lipid metabolism, which in turn triggers Th17 cell growth. Because Th17 cells promote inflammation in both the skin and the blood vessel walls, weight loss serves as a direct way to calm these overactive immune pathways, reducing the severity of psoriasis and potentially lowering cardiovascular risk.

Key Points for Patients

If you have diabetes, obesity, and psoriasis, losing weight through diet and exercise does much more than lower your blood sugar. It can calm down the hyperactive inflammatory cells in your immune system, which helps clear your skin and protect your heart and blood vessels.

Original Research Link: https://doi.org/10.1111/jdi.14037

Historical Review & Translation

Contribution of animal models to diabetes research: Its history, significance, and translation to humans

Author: Soroku Yagihashi

Research Objective

To review and discuss the history, value, and specific contributions of different animal models (especially those with spontaneous diabetes onset) in driving forward modern diabetes research and human therapeutics.

Methods

The author conducted a comprehensive historical review and analysis of animal models used in diabetes studies, examining how well these laboratory models mimic human diabetes and their historical impact on treatment development.

Main Findings

The review highlights that while human clinical trials are essential, appropriate animal models remain absolutely crucial for exploring the deep genetic, metabolic, and physical pathways of diabetes that cannot easily be observed directly in humans. Spontaneous-onset models have played a vital role in identifying new drug therapies.

Clinical Significance

Translating animal research to human clinical practice is a fundamental pillar of modern medicine. This review underscores that continuing to refine and utilize these models is key to addressing the growing global diabetes epidemic and developing more personalized, effective treatments.

Key Points for Patients

Almost every modern diabetes medication and treatment device available today exists because it was first designed, understood, and safely tested using laboratory animal models. This vital step ensures that human therapies are both safe and effective.

Original Research Link: https://doi.org/10.1111/jdi.14034

Basic Science & Kidney Protection

LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy

Authors: Xiangdong Fang, Jianling Song, Yanxia Chen, Shuying Zhu, Weiping Tu, et al.

Research Objective

To discover how high blood sugar (hyperglycemia) causes injury to kidney cells, specifically looking at a unique form of iron-dependent cell death called "ferroptosis," and finding genetic targets to stop it.

Methods

The team used a combination of diabetic mice and human kidney tubular cells in a laboratory. They investigated a non-coding RNA molecule called SNHG1, looking at how its knockdown (turning it off) affects cell damage and kidney markers (like creatinine, urine albumin-creatinine ratio, and urea nitrogen).

Main Findings

The researchers found that SNHG1 was highly elevated in diabetic kidneys. Turning off (knocking down) SNHG1 significantly protected kidney cells from high-sugar-induced cell death. It did this by acting like a shield, releasing a beneficial molecule (miR-16-5p) that blocks a damaging protein (ACSL4) that triggers iron-dependent cell death.

Clinical Significance

Diabetic nephropathy (kidney disease) is a severe complication of diabetes. By uncovering that the SNHG1 / miR-16-5p / ACSL4 axis controls kidney cell death, this study identifies a highly specific target for future genetic or pharmaceutical therapies to protect the kidneys of patients with diabetes.

Key Points for Patients

High blood sugar can cause a specific, iron-driven cell death in your kidneys. While this is basic laboratory research, discovering the specific genetic "switches" (like SNHG1) that control this damage paves the way for future medications that could block kidney damage before it even starts.

Original Research Link: https://doi.org/10.1111/jdi.14036

9/04/2026

Advances in Diabetes Care: Key Insights on Diabetic Complications, Metabolism, and Cardiovascular Health

Journal of Diabetes Investigation (Vol. 13, Issue 10) Summary

The October 2022 issue of the Journal of Diabetes Investigation brings together vital clinical studies and reviews focusing on the early detection of complications, the role of lifestyle in nerve preservation, and novel metabolic pathways. Key themes in this issue include:

Early Predictors of Kidney Damage: Identifying hormonal markers like DHEA to detect diabetic nephropathy before severe progression occurs.
Preventing Nerve Loss: Evidence showing that physical activity and weight-conscious medication selection can help prevent the loss of small nerve fibers in the eye.
Cardiovascular Metrics: Long-term data reinforcing how maintaining normal blood pressure, weight, and physical activity reduces the incidence of type 2 diabetes.
Metabolic Pathways: Exploring how organ-specific serotonin and genetic regulation contribute to energy balance and insulin-producing cell survival.

For patients and families, these findings underscore the profound impact of proactive lifestyle habits—specifically physical activity and cardiovascular health management—in slowing down diabetic complications and protecting long-term organ health.

Diabetic Nephropathy / Kidney Health

Correlation of dehydroepiandrosterone with diabetic nephropathy and its clinical value in early detection

Authors: Ying Ma, Qian Wang, Yunxia Chen, Junping Su, Qian Gao, Yuxin Fan, Jing Feng, Ming Liu, Qing He

Research Objective: To investigate the relationship between the hormone dehydroepiandrosterone (DHEA) and diabetic nephropathy (kidney disease) in individuals with type 2 diabetes, with the goal of improving early prediction of kidney damage.

Methods: A total of 1,082 patients with type 2 diabetes were enrolled. Researchers measured blood levels of DHEA and compared them against indicators of kidney function, such as protein in the urine and creatinine levels.

Main Findings: Patients with diabetic nephropathy had significantly lower DHEA levels compared to those without kidney complications. Low DHEA levels were associated with a longer duration of diabetes, higher blood pressure, and markers of advanced kidney damage. A blood DHEA level threshold of 1,640 pg/mL demonstrated 81.4% sensitivity and 70% specificity in identifying those with kidney disease.

Clinical Significance: DHEA appears to act as a protective factor against kidney damage. Measuring its levels could help doctors predict and spot diabetic kidney disease in its early stages.

Key Point for Patients: DHEA is a natural hormone in our bodies. This study suggests that tracking your DHEA levels might provide doctors with an early warning sign to protect your kidneys from diabetes-related damage.

DOI: https://doi.org/10.1111/jdi.13862

Metabolic Regulation

Serotonin in the regulation of systemic energy metabolism

Authors: Joon Ho Moon, Chang-Myung Oh, Hail Kim

Research Objective: To review how serotonin (commonly known as a brain messenger) controls energy balance across different organs in the body and evaluate its potential for treating metabolic disorders.

Methods: The authors reviewed scientific literature, emphasizing recent discoveries from animal models where serotonin pathways were blocked in specific organs like the liver and fat tissues.

Main Findings: While serotonin in the brain regulates appetite and behavior, serotonin acting in peripheral organs (like fat tissue and the liver) promotes fat storage and can contribute to fatty liver disease. Inhibiting peripheral serotonin has been shown to reduce fat accumulation and improve liver health in animal studies.

Clinical Significance: Modulating peripheral serotonin represents a promising therapeutic avenue for addressing obesity, fatty liver, and metabolic diseases without the negative psychiatric or cardiovascular side effects of older weight-loss medications.

Key Point for Patients: Serotonin is famous as a "happy brain chemical," but it also controls how our bodies store fat. Scientists are looking for ways to block peripheral serotonin to help treat obesity and fatty liver in the future.

DOI: https://doi.org/10.1111/jdi.13879

Diabetic Neuropathy / Nerve Damage

Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes

Authors: Georgios Ponirakis, Ibrahim Al-Janahi, Einas Elgassim, Hoda Gad, Ioannis N Petropoulos, et al.

Research Objective: To identify the clinical and lifestyle risk factors associated with the worsening of diabetic peripheral neuropathy (nerve damage) over a two-year period.

Methods: 78 participants with type 2 diabetes and 26 healthy control subjects underwent examinations at baseline and after 2 years. Nerve fibers in the eye (cornea) were evaluated non-invasively using corneal confocal microscopy (CCM), alongside standard nerve examinations and surveys.

Main Findings: Over 2 years, diabetic patients showed a progressive loss of corneal nerve fibers. However, this nerve damage worsened only in patients who were physically inactive or taking diabetes medications associated with weight gain. Nerve structure remained stable in those who were physically active or on diabetes medications linked to weight loss.

Clinical Significance: Protecting small nerve fibers from deterioration may depend heavily on keeping physically active and avoiding medications that promote weight gain.

Key Point for Patients: To protect your body's delicate nerves, physical activity and discussing weight-friendly diabetes medications with your doctor are highly beneficial strategies, even if your average blood sugar (HbA1c) is stable.

DOI: https://doi.org/10.1111/jdi.13864

Cellular Breakthroughs

Identification of islet cell characteristics in humans with type 2 diabetes by single-cell sequencing

Authors: Junta Imai

Research Objective: To highlight recent advances in mapping cellular protein activity within human insulin-producing beta cells to find ways to prevent beta-cell failure.

Methods: This commentary highlights a key study by Son et al. that used advanced single-cell genetic sequencing to examine the cells inside the pancreas of individuals with type 2 diabetes.

Main Findings: The reviewed study successfully identified changes in specific regulatory proteins in human beta cells that occur in type 2 diabetes. These proteins are involved in cellular survival and function.

Clinical Significance: Understanding these molecular changes provides key blueprints to design therapies that can preserve or rescue insulin-secreting cells before they stop functioning entirely.

Key Point for Patients: Scientists are using advanced technology to study human insulin-producing cells on a single-cell level. This is leading to deep insights that could help create medicines to protect these cells in the future.

DOI: https://doi.org/10.1111/jdi.13833

Emergency Case Report

Serious diabetic ketoacidosis induced by insulin allergy and anti-insulin antibody in an individual with type 2 diabetes mellitus

Authors: Kaio Takahashi, Takatoshi Anno, Haruka Takenouchi, Hideyuki Iwamoto, Megumi Horiya, et al.

Research Objective: To document a rare and critical case of diabetic ketoacidosis (DKA) caused by an immune allergy to insulin and the presence of anti-insulin antibodies in a patient with type 2 diabetes.

Methods: A detailed case analysis of a patient with type 2 diabetes who developed severe insulin resistance and subsequent DKA while receiving insulin therapy.

Main Findings: The patient's body developed an allergic reaction and antibodies that neutralized the prescribed insulin. This led to extreme insulin deficiency in the body. Resolving this crisis required administering exceptionally high doses of insulin alongside careful monitoring of the blood's acid balance (pH and base excess).

Clinical Significance: This case reminds healthcare teams that insulin allergy and anti-insulin antibodies can cause severe DKA even in patients with type 2 diabetes, requiring high doses of insulin and intensive critical care.

Key Point for Patients: Although extremely rare, the human body can sometimes treat injected insulin as an allergen and fight it off. Recognizing this unusual cause of insulin resistance is critical for doctors treating sudden, severe blood sugar emergencies.

DOI: https://doi.org/10.1111/jdi.13838

Maternal & Child Health

Hyperglycemia-mediated oocyte TET3 insufficiency predisposing offspring to glucose intolerance

Authors: Xiumei Wu, Suowen Xu, Jianping Weng

Research Objective: To review how high blood sugar in mothers prior to pregnancy changes the genetic markings in egg cells, which can predispose their offspring to diabetes.

Methods: This commentary highlights key scientific evidence published in Nature by Chen et al., examining the epigenetic molecular pathways in egg cells (oocytes).

Main Findings: High blood sugar before pregnancy reduces a specific enzyme called TET3 in egg cells. This deficiency leads to abnormal DNA modifications (hypermethylation), which decreases the activity of genes responsible for insulin secretion in the child later in life.

Clinical Significance: This provides a molecular mechanism showing why a mother's blood sugar health before conception is crucial for preventing future diabetes in her children.

Key Point for Patients: Managing blood sugar levels before becoming pregnant is incredibly important. High sugar can modify the "chemical tags" on egg cells, potentially raising a child's risk of future blood sugar issues.

DOI: https://doi.org/10.1111/jdi.13885

Prevention & Lifestyle

Association of ideal cardiovascular health metrics and incident type 2 diabetes mellitus among an urban population of Iran: One decade follow up in the Tehran Lipid and Glucose Study

Authors: Samaneh Asgari, Soroush Masrouri, Somaye Hosseinpour-Niazi, Nazanin Moslehi, Fereidoun Azizi, Farzad Hadaegh

Research Objective: To examine the association between meeting ideal cardiovascular health metrics (ICVHM) and the long-term risk of developing type 2 diabetes.

Methods: Researchers followed 7,488 Iranian adults without diabetes at baseline for an average of 9.1 years. Heart-health factors evaluated included body weight, blood pressure, cholesterol, diet, and physical activity.

Main Findings: Over the study period, 922 new cases of type 2 diabetes were identified. Having a higher overall heart-health score was strongly linked to a lower risk of developing diabetes. This protection was mostly driven by maintaining a normal body weight, normal blood pressure, and participating in intensive physical activity (particularly for men).

Clinical Significance: Actively improving and maintaining core heart health metrics is a highly effective way to prevent the development of diabetes.

Key Point for Patients: Heart health and diabetes prevention go hand-in-hand. Keeping your blood pressure in a normal range, staying active, and maintaining a healthy weight are some of the most powerful steps you can take to avoid developing diabetes.

DOI: https://doi.org/10.1111/jdi.13839

Post-Surgical Management

Perioperative C-peptide index is associated with the status of diabetes management after pancreatectomy

Authors: Masataka Shikata, Daisuke Chujo, Asako Enkaku, Akiko Takikawa-Nishida, Hisae Honoki, et al.

Research Objective: To identify how pre-surgical diabetes status and remaining insulin-producing capacity (measured by C-peptide index, or CPI) affect blood sugar control after a portion of the pancreas is surgically removed (pancreatectomy).

Methods: Clinical data and pre- and post-operative CPI were analyzed in 47 patients who underwent pancreatic surgery, tracking their diabetes medication needs and blood sugar management at 6 months.

Main Findings: Patients with lower post-operative insulin-producing capacity (low CPI) had a longer pre-surgical duration of diabetes and used more diabetes medications before surgery. Patients with higher CPI levels after surgery had better blood sugar levels (HbA1c < 7.0%) and were significantly less likely to require insulin injections.

Clinical Significance: Knowing a patient's historical diabetes status and their C-peptide levels around the time of surgery helps doctors predict and better manage how their blood sugar will behave after losing part of their pancreas.

Key Point for Patients: If you face pancreas surgery, your previous history of diabetes and remaining insulin-making capacity will guide your healthcare team in planning the safest, most effective way to manage your blood sugar after the operation.

DOI: https://doi.org/10.1111/jdi.13861